> top > docs > PMC:7600245 > spans > 54786-54996 > annotations

PMC:7600245 / 54786-54996 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T239 109-117 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T240 152-187 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T241 158-187 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T550 41-42 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T63616 4-8 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T56 158-178 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T407 0-210 Sentence denotes The drug is currently being evaluated in a phase 2 randomized, placebo-controlled study for the treatment of SARS-CoV-2 in patients at elevated risk of acute respiratory distress syndrome (NCT04388826; n = 40).

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1687 109-119 Species denotes SARS-CoV-2 Tax:2697049
1688 123-131 Species denotes patients Tax:9606
1696 152-187 Disease denotes acute respiratory distress syndrome MESH:D012128